Showing results (951-960 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|July 11, 2022
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorderPaolo Olgiati, Giuseppe Fanelli, Anna Rita Atti, et al.International Clinical Psychopharmacology|July 14, 2022
Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals?Julie Giustiniani, Stéphane Rothen, Louise Penzenstadler, et al.International Clinical Psychopharmacology|January 12, 2016
The clock-drawing test as a possible indicator of acute psychosisOren Tene, Mayanit Sigler, Roni Shiloh, et al.International Clinical Psychopharmacology|January 1, 1989
Spontaneous motor activity in healthy volunteers after single doses of haloperidolS Frey, G Bente, A Fuchs, et al.International Clinical Psychopharmacology|January 1, 1989
Effects of dihydroergotamine on psychomotor function, neuroendocrine parameters and blood pressure, in healthy volunteersP Danjou, L Lacomblez, D Warot, et al.International Clinical Psychopharmacology|January 1, 1989
Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorderU von Bardeleben, F Holsboer, A Gerken, et al.International Clinical Psychopharmacology|January 1, 1989
A comparative trial of a new antidepressant, fluoxetineS Levine, R Deo, K MahadevanInternational Clinical Psychopharmacology|January 1, 1989
Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disordersV Manna, N Martucci, A AgnoliInternational Clinical Psychopharmacology|January 1, 1989
Fluoxetine versus amineptine in the treatment of outpatients with major depressive disordersM FerreriInternational Clinical Psychopharmacology|January 8, 2015
Gene polymorphisms potentially related to the pharmacokinetics of clozapine: a systematic reviewAmir Krivoy, Fiona Gaughran, Abraham Weizman, et al.Pageof 212